Method for the treatment of polycystic kidney disease

Details for Australian Patent Application No. 2005294258 (hide)

Owner Wyeth

Inventors Frost, Philip

Agent Davies Collison Cave

Pub. Number AU-A-2005294258

PCT Pub. Number WO2006/042100

Priority 60/616,981 08.10.04 US

Filing date 7 October 2005

Wipo publication date 20 April 2006

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/47 (2006.01) - Quinolines

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61K 31/5513 (2006.01)

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/042100 Priority application(s): WO2006/042100

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005294265-Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway

2005294257-Amitraz compositions